[Form 3] Guardant Health, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Alex M. Azar II filed an initial Form 3 reporting his role with Guardant Health, Inc. (GH) as a Director. The event date requiring the statement is 09/12/2025. The filing discloses 0 shares of common stock beneficially owned, reported as direct ownership. The form is signed by an attorney-in-fact on behalf of Mr. Azar on 09/26/2025.

Insights

Corporate Governance Expert

TL;DR: Routine disclosure of direct beneficial ownership with no shares reported; governance signal is neutral.

The Form 3 confirms Alex M. Azar II is recorded as a Director of Guardant Health and that he currently holds no direct common stock in the issuer according to this filing. As an initial statement, it documents the statutory reporting obligation under Section 16 but does not disclose any equity holdings or derivative positions that would affect voting or compensation alignment with shareholders.

Securities Analyst

TL;DR: No material economic position disclosed; the filing is informational and unlikely to move market views.

The filing lists 0 shares of common stock beneficially owned and shows the reporting relationship as Director. There are no derivative securities, transactions, or holdings disclosed. For investors, this is a routine compliance filing establishing the reporting baseline rather than signaling a change in ownership or control.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Azar Alex M II

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/12/2025

3. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Alex M. Azar II	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 3 for Guardant Health (GH)?

The Form 3 was filed on behalf of Alex M. Azar II, with the signature executed by an attorney-in-fact, John G. Saia.

What relationship does the reporting person have to Guardant Health (GH)?

The reporting person is listed as a Director of Guardant Health.

How many shares does Alex M. Azar II report owning in GH?

The filing reports 0 shares of common stock beneficially owned, with ownership form marked as Direct (D).

What is the date of the event requiring the Form 3 filing?

The date of the event requiring the statement is 09/12/2025.

When was the Form 3 signed?

The signature block shows the form signed by the attorney-in-fact on 09/26/2025.